reference/15352373

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15352373

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	553
issn	1610-2940 0948-5023
issueIdentifier	3
pageRange	543-553
publicationName	Journal of Molecular Modeling
startingPage	543
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0d6786c14e35ab0c92ab634e52de5d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63fe94d5caac03c098dc459168739a10 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e6c5305d51b0aba87910cd53f4afdded
bibliographicCitation	Lu P, Bevan DR, Lewis SN, Hontecillas R, Bassaganya-Riera J. Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics. Journal of Molecular Modeling. 2010 May 30;17(3):543–53. doi: 10.1007/s00894-010-0748-y.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50f854af36e6451c8cc2bdc666b2a37a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_981a5317a178cba48846de841e8183db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dc17b97b66cd9be038cf31407271116 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fd761df13ebf11bb4607d0f65bd0b87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1962-5783 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7652fdb0daa67b0a2ee04894aa99715d
date	2010-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00894-010-0748-y https://pubmed.ncbi.nlm.nih.gov/20512604
isPartOf	https://portal.issn.org/resource/ISSN/0948-5023 https://portal.issn.org/resource/ISSN/1610-2940 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21571
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics
discusses	http://id.nlm.nih.gov/mesh/M0013341 http://id.nlm.nih.gov/mesh/M0199114 http://id.nlm.nih.gov/mesh/M0443139 http://id.nlm.nih.gov/mesh/M0012508 http://id.nlm.nih.gov/mesh/M0075849 http://id.nlm.nih.gov/mesh/M0000061 http://id.nlm.nih.gov/mesh/M0015042 http://id.nlm.nih.gov/mesh/M0452127 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0446414
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280896 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_38ca895fb47c55c08b93484274f41182 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID256406 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8180 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e17e5229d402894eeb552cc65cb18a20 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5375199 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5375200 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89e9f4aeaf8310fa97640dc7bc8256d1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102950 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98504 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131954763 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID287291 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4829 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702609

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127797553 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128291602 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127863084 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55915 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128240590

Total number of triples: 63.